¼¼°èÀÇ À̹Ì¡¿ë È­ÇÐÁ¦Ç° ½ÃÀå : Á¦Ç° À¯Çüº°, ¿ëµµº°, Á¦Á¦º°, ÃÖÁ¾ »ç¿ëÀÚº°, ±¹°¡º°, Áö¿ªº° »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2025-2032³â)
Imaging Chemicals Market, By Product Type, By Application, By Formulation, By End-user, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
»óǰÄÚµå : 1808828
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 355 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,674,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,688,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 8,126,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

À̹Ì¡¿ë È­ÇÐÁ¦Ç° ½ÃÀåÀÇ ±Ô¸ð´Â 2024³â¿¡ 34¾ï 567¸¸ ´Þ·¯·Î Æò°¡µÇ¾úÀ¸¸ç 2025³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 6.5%·Î È®´ëµÉ Àü¸ÁÀÔ´Ï´Ù.

À̹Ì¡¿ë È­ÇÐÁ¦Ç° ½ÃÀåÀº ÀÇ·á À̹Ì¡, »çÁø À̹Ì¡, Àμâ, »ê¾÷¿ë ºñÆÄ±« °Ë»ç¿Í °°Àº À̹Ì¡ ±â¼ú¿¡ »ç¿ëµÇ´Â È­ÇÐ È­ÇÕ¹°·Î ±¸¼ºµË´Ï´Ù. ÀÌ·¯ÇÑ È­Çй°ÁúÀº ´Ù¾çÇÑ À̹Ì¡ ½Ã½ºÅÛ¿¡¼­ À̹ÌÁö Çö»ó, °³¼±, Á¤Âø ¹× ¼¼Ã´ °úÁ¤¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀÇ·á Áø´Ü¿¡¼­´Â X¼±, MRI, CT, ÃÊÀ½ÆÄ °Ë»ç¿¡ ³Î¸® »ç¿ëµÇ¾î ½ÃÀμº°ú È­ÁúÀ» Çâ»ó½Ãŵ´Ï´Ù. »çÁø°ú Àμ⿡¼­ À̹Ì¡¿ë È­ÇÐÁ¦Ç°Àº Çʸ§°ú Á¾ÀÌ À̹ÌÁöÀÇ Çö»ó°ú ¾ÈÁ¤È­¸¦ µµ¿ÍÁÝ´Ï´Ù.

ÀÌ ½ÃÀåÀº Á¤¹Ð À̹ÌÁö°¡ ÇʼöÀûÀÎ ¸¶ÀÌÅ©·Î ÀÏ·ºÆ®·Î´Ð½º ¹× ¹ÝµµÃ¼ ¸®¼Ò±×·¡Çǿ͵µ ´ëÀÀÇϰí ÀÖ½À´Ï´Ù. ¼ö¿äÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ´Â °ÍÀº ÇコÄɾî Áø´ÜÀÇ Áõ°¡, »ó¾÷ Æ÷Àå¿¡¼­ÀÇ Àμ⠿䱸ÀÇ Áõ°¡, µðÁöÅÐ À̹Ì¡ÀÇ Áøº¸ÀÔ´Ï´Ù. ¶ÇÇÑ ÀÇ·á ÀÎÇÁ¶ó ¹× ¿¬±¸ ÅõÀÚ Áõ°¡°¡ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ȯ°æ ¹®Á¦¿¡ ´ëÇÑ ¿ì·Á·Î ȯ°æÄ£È­ÀûÀÎ »ýºÐÇØ¼º À̹Ì¡¿ë È­ÇÐÁ¦Ç°ÀÌ °³¹ßµÇ¾ú½À´Ï´Ù. ¶ÇÇÑ, µðÁöÅÐ À̹Ì¡°ú ÇÏÀ̺긮µå À̹Ì¡À¸·ÎÀÇ Àüȯµµ ³ªÅ¸³ª°í ÀÖÀ¸¸ç, °¢ Á¦Á¶¾÷ü´Â Áö¼Ó °¡´ÉÇÑ Á¦Á¦ÀÇ Çõ½Å¿¡ ÀÓÇϰí ÀÖ½À´Ï´Ù.

À̹Ì¡¿ë È­ÇÐÁ¦Ç° ½ÃÀå - ½ÃÀå ¿ªÇÐ

°í±Þ ¿µ»ó Áø´Ü¿¡¼­ÀÇ Á¶¿µÁ¦ ¼ö¿ä Áõ°¡

À̹Ì¡¿ë È­ÇÐÁ¦Ç° ½ÃÀåÀÇ Æ´»õ ÃËÁø ¿äÀÎ Áß Çϳª´Â °í±Þ À̹Ì¡¿¡¼­ÀÇ Á¶¿µÁ¦ ¼ö¿äÀÇ È®´ëÀÔ´Ï´Ù. Á¶¿µÁ¦´Â ½Åü ±¸Á¶ÀÇ °¡½Ã¼ºÀ» ³ôÀ̰í Àǻ簡 ÀÌ»óÀ» ½±°Ô ãÀ» ¼ö ÀÖµµ·Ï ¿µ»ó Áø´Ü¿¡ »ç¿ëµÇ´Â Çʼö È­ÇÐ ¹°ÁúÀÔ´Ï´Ù. MRI, CT ½ºÄµ, Ç÷°ü Á¶¿µ¼ú µî ÀÇ·á ¿µ»ó ±â¼úÀÌ °íµµÈ­µÊ¿¡ µû¶ó °íǰÁú Á¶¿µÁ¦¿¡ ´ëÇÑ ¿ä±¸°¡ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. ÀÌ ¾àÀº Á¶Á÷, Ç÷°ü ¹× ±â°üÀ» ±¸º°ÇÏ´Â µ¥ µµ¿òÀÌ µÇ¸ç º¸´Ù Á¤È®ÇÑ Áø´ÜÀ¸·Î À̾îÁý´Ï´Ù.

¾ÏÀ̳ª ½ÉÇ÷°ü Áúȯ µîÀÇ ¸¸¼º ÁúȯÀÇ À¯ÇàÀÌ ³ô¾ÆÁü¿¡ µû¶ó, Á¤È®Çϰí Á¶±â¿¡ ¹ß°ßÇÒ ¼ö ÀÖ´Â Åø¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö¸é¼­ À̹Ì¡¿ë È­ÇÐÁ¦Ç°ÀÇ »ç¿ëÀ» ´õ¿í µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ½ÅÈï±¹¿¡¼­´Â °í·ÉÈ­°¡ ÁøÇàµÇ°í ÇコÄÉ¾î ¼­ºñ½º¿¡ÀÇ ¾×¼¼½º°¡ Çâ»óµÇ°í ÀÖ¾î, Áø´Ü °Ë»ç¸¦ ¹Þ´Â ȯÀÚÃþÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. Àúµ¶¼º ¹× Ç¥Àû ¾à¹°°ú °°Àº Á¶¿µÁ¦ÀÇ ±â¼úÀû Áøº¸µµ ½ÃÀå ¼ºÀåÀ» Áö¿øÇÕ´Ï´Ù. °Ô´Ù°¡, ¸ÂÃãÇü ÀǷᳪ ºÐÀÚ À̹Ì¡¿¡ °üÇÑ ¿¬±¸°¡ ÁøÇàµÇ°í ÀÖ´Â °Íµµ °³º° ȯÀÚ¿¡ ¸ÂÃá Æ¯¼öÇÑ Á¶¿µÁ¦ÀÇ °³¹ßÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ÀÌ µ¿ÇâÀº °íÇØ»óµµ Áø´ÜÀ» ÅëÇØ ÀÇ·á ¼º°ú¸¦ Çâ»ó½ÃŰ´Â µ¥ À̹Ì¡¿ë È­ÇÐÁ¦Ç°ÀÌ °¡Áö´Â Áß¿äÇÑ ¿ªÇÒÀ» ¹Ý¿µÇϰí ÀÖ½À´Ï´Ù.

À̹Ì¡¿ë È­ÇÐÁ¦Ç° ½ÃÀå - ÁÖ¿ä ÀλçÀÌÆ®

Á¶»ç ºÐ¼®°¡ÀÇ ºÐ¼®¿¡ µû¸£¸é ¼¼°è ½ÃÀåÀº ¿¹Ãø ±â°£(2025-2032³â)¿¡ ¾à 6.5%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¸Å³â ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

Á¦Ç° À¯Çüº°·Î´Â MRI Á¶¿µÁ¦°¡ 2024³â¿¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» ³ªÅ¸³Â½À´Ï´Ù.

¿ëµµº°·Î´Â ÀÇ·á Áø´ÜÀÌ 2024³âÀÇ ÁÖ¿ä ¿ëµµ·Î ³ªÅ¸³µ½À´Ï´Ù.

Á¦Çüº°·Î´Â 2024³â¿¡´Â Á¤ÂøÁ¦°¡ ÁÖ¿ä Á¦ÇüÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù.

Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2024³â ¸ÅÃâÀ» ÁÖµµÇÏ¿´½À´Ï´Ù.

À̹Ì¡¿ë È­ÇÐÁ¦Ç° ½ÃÀå - ¼¼ºÐÈ­ ºÐ¼®

¼¼°èÀÇ À̹Ì¡¿ë È­ÇÐÁ¦Ç° ½ÃÀåÀº Á¦Ç° À¯Çü, ¿ëµµ, Á¦Çü, ÃÖÁ¾ »ç¿ëÀÚ ¹× Áö¿ª¿¡ µû¶ó ¼¼ºÐÈ­µË´Ï´Ù.

Á¦Ç°Àº À¯Çüº°·Î ¿¢½º·¹ÀÌ À̹Ì¡¿ë È­ÇÐÁ¦Ç°, MRI Á¶¿µÁ¦, ÃÊÀ½ÆÄ Á¶¿µÁ¦, »çÁø¿ë È­ÇÐÁ¦Ç°, Àμâ À̹Ì¡¿ë È­ÇÐÁ¦Ç°, »ê¾÷ À̹Ì¡¿ë È­ÇÐÁ¦Ç°ÀÇ 6°¡Áö·Î ºÐ·ùµË´Ï´Ù. Á¦Ç° À¯Çüº°·Î´Â ÀÇ·á Áø´ÜÀÌ À̹Ì¡¿ë È­ÇÐÁ¦Ç° ½ÃÀå¿¡¼­ °¡Àå ¶Ù¾î³­ ½ÇÀûÀ» º¸À̰í ÀÖ½À´Ï´Ù. ÀÇ·á Áø´ÜÀº º¹ÀâÇÑ º´¸®¸¦ Á¤È®ÇÏ°Ô Áø´ÜÇϱâ À§ÇØ ³»Àå, Á¶Á÷ ¹× Ç÷°ü ±¸Á¶¸¦ ½Ã°¢È­ÇÔÀ¸·Î½á Àڱ⠰ø¸í ¿µ»ó Áø´Ü¿¡ ³Î¸® Àû¿ëµË´Ï´Ù. ÀÌ´Â ½Å°æ Áúȯ, ½ÉÇ÷°ü Áúȯ, ¾Ï °ü·Ã ÁúȯÀÌ ¼¼°èÀûÀ¸·Î Áõ°¡ÇÏ´Â Ãß¼¼¿¡ ÀÖ°í, °íÁ¤¹ÐµµÀÇ À̹Ì¡¿¡ ÁÖ·ÂÇÒ Çʿ伺ÀÌ ¼ö¹ÝµÈ´Ù´Â »ç½Ç¿¡ ÀÇÇØ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù.

¶ÇÇÑ ºñħ½À¼º ¹× ºñÀü¸® ¹æ»ç¼±°ú °ü·ÃµÈ ƯÁ¤ À¯ÇüÀº MRIÀÔ´Ï´Ù. ´õ ³ªÀº Áø´Ü ±â¼ú¿¡ ´ëÇÑ ÅõÀÚ¿Í ÇÔ²² °Ç°­ °ü¸® ½Ã½ºÅÛ¿¡ ´ëÇÑ °ü½ÉÀÌ Áõ°¡ÇÔ¿¡ µû¶ó MRI Á¶¿µÁ¦ÀÇ »ç¿ë¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. º¸´Ù ¾ÈÀüÇÏ°í ³·Àº µ¶¼ºÀ» °¡Áø Á¶¿µÁ¦ Á¦ÇüÀÇ °³¹ß°ú Ç¥ÀûÈ­ Á¶¿µÁ¦ÀÇ Áøº¸´Â Á¶¿µÁ¦ÀÇ ÀÀ¿ëÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ °í·ÉÈ­ »çȸÀÇ µµ·¡¿Í Áúº´ÀÇ Á¶±â Áø´Ü¿¡ °üÇÑ Áö½Ä Áõ°¡µµ ÀÌ ºÐ¾ßÀÇ ÁÖµµ±ÇÀ» Àâ´Â ¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù.

½ÃÀåÀº ¿ëµµ¿¡ µû¶ó ÀÇ·á Áø´Ü, »çÁø, ÀÎ¼â ¹× Æ÷Àå, ÅØ½ºÅ¸ÀÏ ¹× À̹Ì¡, ¹ÝµµÃ¼ ¹× ÀÏ·ºÆ®·Î´Ð½º, °ø¾÷¿ë ºñÆÄ±« °Ë»ç(NDT)ÀÇ ¹üÁÖ·Î ³ª´¹´Ï´Ù. ÀÇ·á Áø´ÜÀº À̹Ì¡¿ë È­ÇÐÁ¦Ç° ½ÃÀåÀÇ ¿ëµµº° ºÎ¹® Áß °¡Àå °­·ÂÇÑ ºÎ¹®ÀÔ´Ï´Ù. ÀÌ ºÐ¾ß´Â MRI, CT ½ºÄµ, X-¼±, ÃÊÀ½ÆÄ µî Áúº´ÀÇ °ËÃâ ¹× ¸ð´ÏÅ͸µÀ» À§ÇÑ À̹Ì¡ ±â¹ýÀÌ º¸±ÞµÇ¾î Àֱ⠶§¹®¿¡ ÃÖÀü¼±¿¡ ÀÖ½À´Ï´Ù. Á¶¿µÁ¦(À̹Ì¡¿ë È­ÇÐÁ¦Ç°)ÀÇ °ËÃâ°ú ½Ã°¢È­´Â Áø´Ü À̹ÌÁöÀÇ ¼±¸íµµ¿Í Á¤¹Ðµµ¸¦ ³ôÀ̱â À§ÇØ ÇÊ¿äÇÕ´Ï´Ù. ¾Ï, ½ÉÇ÷°ü Áúȯ, ½Å°æ Áúȯ°ú °°Àº ¸¸¼º ÁúȯÀÇ Àü¹ÝÀûÀÎ ºÎ´ã Áõ°¡¸¦ ¼ö¿ëÇϱâ À§Çؼ­´Â Á¤È®ÇÑ ¿µ»ó Áø´Ü ¼Ö·ç¼ÇÀÌ ÇÊ¿äÇÕ´Ï´Ù.

ƯÈ÷ ½ÅÈï°æÁ¦±¹¿¡¼­´Â ÀÇ·á ÀÎÇÁ¶óÀÇ ¼ºÀå°ú ÇÔ²² ¿µ»ó Áø´Ü ÀåºñÀÇ ±â¼úÀû ¿òÁ÷ÀÓÀÌ ´õ¿í ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. °í·ÉÈ­ Àα¸ Áõ°¡¿Í Á¶±â Áø´Ü ÇÁ·Î±×·¥µµ È­»ó 󸮷® Áõ°¡ ¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÀÌ ºÐ¾ß´Â ³·Àº À§Çè°ú ȯÀÚģȭÀûÀÎ È­ÇÐÁ¦Á¦ÀÇ °³¹ßÀ» Áö¼ÓÇÏ¿© ¼º°øÀ» °ÅµÎ°í ÀÖ½À´Ï´Ù. Àü¹ÝÀûÀ¸·Î ÀÇ·á Áø´ÜÀÌ ½ÃÀå ¹ßÀüÀÇ ÃÊÁ¡ÀÌ µÉ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

À̹Ì¡¿ë È­ÇÐÁ¦Ç° ½ÃÀå - Áö¸®Àû ÀλçÀÌÆ®

ºÏ¹ÌÀÇ À̹Ì¡¿ë È­ÇÐÁ¦Ç° ½ÃÀåÀº ÁÖ·Î °í±Þ ÀÇ·á ÀÎÇÁ¶óÀÇ Á¸Àç¿Í À̹Ì¡ ¼ö¿ä Áõ°¡¿¡ ÀÇÇØ °ßÀεǰí ÀÖ½À´Ï´Ù. ¹Ì±¹Àº ÀÇ·á±â¼ú¿¡ ´ëÇÑ ÅõÀÚ°¡ ³ô°í CT, MRI, X¼± ÀÀ¿ë ºÐ¾ß¿¡¼­ Á¶¿µÁ¦°¡ ³Î¸® »ç¿ëµÇ°í Àֱ⠶§¹®¿¡ ÀÌ Áö¿ª ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Á¤È®ÇÑ Á¶±â ¹ß°ßÀÌ ÇÊ¿äÇÑ ¸¸¼º ÁúȯÀÇ Áõ°¡µµ ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ÀÎ¼â ¹× Æ÷Àå ºÐ¾ß´Â Æ¯È÷ °íÇØ»óµµ·Î ³»±¸¼ºÀÌ ÀÖ´Â Àμ⹰¿¡ ´ëÇÑ ¼ö¿ä°¡ °è¼ÓµÇ°í Àֱ⠶§¹®¿¡ Å©°Ô °øÇåÇϰí ÀÖ½À´Ï´Ù.

¹Ì±¹¿¡¼­´Â ȯ°æÄ£È­ÀûÀÌ°í µðÁöÅÐ ¹æ½ÄÀ¸·Î ȣȯµÇ´Â À̹Ì¡¿ë È­ÇÐÁ¦Ç°ÀÇ ±â¼úÀû Áøº¸°¡ ºü¸£°Ô äÅõǰí ÀÖ½À´Ï´Ù. FDA ¹× EPA¿Í °°Àº ±â°üÀÇ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©´Â º¸´Ù ¾ÈÀüÇÏ°í µ¶¼ºÀÌ ³·Àº È­Çй°Áú °³¹ß¿¡ ¿µÇâÀ» ¹ÌĨ´Ï´Ù. ij³ª´Ù¿¡¼­´Â ÀÇ·á Áø´Ü ¹× »ê¾÷¿ë À̹ÌÁö 󸮿¡ ´ëÇÑ ÅõÀÚ°¡ È®´ëµÇ°í ÀÖ½À´Ï´Ù. Áö¿ª ±â¾÷Àº ¶ÇÇÑ È¯°æ ±âÁØÀ» ÃæÁ·Çϱâ À§ÇØ Áö¼Ó °¡´ÉÇÑ Á¦ÇüÀ» °­Á¶ÇÕ´Ï´Ù. Á¦Á¶¾÷ü¿Í ÀÇ·á Á¦°ø¾÷ü °£ÀÇ Á¶»ç ¹× Çù·ÂÀº ÀÌ ºÐ¾ßÀÇ Çõ½ÅÀ» ´õ¿í °­È­Çϰí ÀÖ½À´Ï´Ù.

À̹Ì¡¿ë È­ÇÐÁ¦Ç° ½ÃÀå - °æÀï ±¸µµ

À̹Ì¡¿ë È­ÇÐÁ¦Ç° ½ÃÀåÀÇ °æÀï ±¸µµ´Â ±â¼ú Çõ½Å°ú Áö¼Ó °¡´É¼º¿¡ ÁßÁ¡À» µÐ ¼¼°è ±â¾÷°ú Áö¿ª ±â¾÷ÀÇ Á¸À縦 Ư¡À¸·Î ÇÕ´Ï´Ù. Fujifilm, Agfa-Gevaert, Eastman Kodak µîÀÇ ±â¾÷ÀÌ Æø³ÐÀº Á¦Ç° Æ÷Æ®Æú¸®¿À¿Í °­·ÂÇÑ R&D ´É·ÂÀ¸·Î ¿ìÀ§¸¦ Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ½ÃÀåÀº Àû´çÈ÷ ÅëÇյǾî ÀÖÀ¸¸ç ÀÇ·á¿ë ¹× »çÁø¿ë À̹Ì¡ ºÐ¾ß¿¡¼­ ¼Ò¼öÀÇ ´ë±â¾÷ÀÌ Å« Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. °æÀï ¿ìÀ§¸¦ ¾ò±â À§Çؼ­´Â Àü·«Àû Á¦ÈÞ, Àμö, Áö¸®Àû È®´ë°¡ ÀϹÝÀûÀ¸·Î ÇàÇØÁö°í ÀÖ½À´Ï´Ù. ±â¾÷Àº ȯ°æ ±ÔÁ¦¿Í ¼ÒºñÀÚ ¼ö¿ä¿¡ ´ëÀÀÇϱâ À§ÇØ È¯°æÄ£È­ÀûÀÎ »ýºÐÇØ¼º È­Çй°Áú¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾ç¿¡¼­´Â ƯÈ÷ ÀϺ»°ú Áß±¹ÀÌ Ã·´Ü »ý»ê ±â¼úÀ» °®Ãá ÁÖ¿ä Á¦Á¶¾÷ü¸¦ º¸À¯Çϰí ÀÖ½À´Ï´Ù. ´ëÁ¶ÀûÀ¸·Î, ºÏ¹Ì¿Í À¯·´ ±â¾÷Àº °Ç°­ °ü¸® À̹Ì¡°ú µðÁöÅÐ Àμ⿡ ÁßÁ¡À» µÓ´Ï´Ù. °æÀï¾÷ü¿ÍÀÇ °¡°Ý °æÀï°ú Á¦Ç° Â÷º°È­´Â ÀÌ ºÐ¾ß¿¡¼­ ÇʼöÀûÀÎ Àü·«ÀÔ´Ï´Ù. °Ô´Ù°¡ Áø´Ü¿ëÀ̳ª »ê¾÷¿ëÀÇ È­»ó 󸮿¡ ƯȭÇÑ Á¦Á¦¸¦ °¡Áö´Â Æ´»õ Á¦Á¶¾÷üµµ ´ëµÎÇØ ¿Ô½À´Ï´Ù. Á¶¿µÁ¦¿Í µðÁöÅÐ ´ëÀÀ È­Çй°ÁúÀÇ Çõ½ÅÀÌ ÇâÈÄ Àü¸ÁÀ» Çü¼ºÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå À̹Ì¡¿ë È­ÇÐÁ¦Ç° ½ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå À̹Ì¡¿ë È­ÇÐÁ¦Ç°ÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå À̹Ì¡¿ë È­ÇÐÁ¦Ç° »ê¾÷ÀÇ Á¶»ç

Á¦5Àå À̹Ì¡¿ë È­ÇÐÁ¦Ç° ½ÃÀå : ³ô¾ÆÁö´Â ÁöÁ¤ÇÐÀû ±äÀåÀÇ ¿µÇâ

Á¦6Àå À̹Ì¡¿ë È­ÇÐÁ¦Ç° ½ÃÀå »óȲ

Á¦7Àå À̹Ì¡¿ë È­ÇÐÁ¦Ç° ½ÃÀå - Á¦Ç° À¯Çü

Á¦8Àå À̹Ì¡¿ë È­ÇÐÁ¦Ç° ½ÃÀå - ¿ëµµº°

Á¦9Àå À̹Ì¡¿ë È­ÇÐÁ¦Ç° ½ÃÀå - Á¦Çüº°

Á¦10Àå À̹Ì¡¿ë È­ÇÐÁ¦Ç° ½ÃÀå - ÃÖÁ¾ »ç¿ëÀÚº°

Á¦11Àå À̹Ì¡¿ë È­ÇÐÁ¦Ç° ½ÃÀå - Áö¿ª

Á¦12Àå ÁÖ¿ä º¥´õ ºÐ¼® - À̹Ì¡¿ë È­ÇÐÁ¦Ç° »ê¾÷

Á¦13Àå ¾Ö³Î¸®½ºÆ®ÀÇ Á¾ÇÕÀû Àü¸Á

CSM
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Imaging Chemicals Market size was valued at US$ 3,405.67 Million in 2024, expanding at a CAGR of 6.5% from 2025 to 2032.

The Imaging Chemicals Market comprises chemical compounds used in imaging technologies such as medical imaging, photographic imaging, printing, and industrial non-destructive testing. These chemicals play a crucial role in image development, enhancement, fixation, and cleaning processes across various imaging systems. In medical diagnostics, they are widely used in X-ray, MRI, CT, and ultrasound procedures to improve visibility and image quality. In photography and printing, imaging chemicals assist in developing and stabilizing images on film and paper.

The market also caters to microelectronics and semiconductor lithography, where precision imaging is essential. Demand is driven by rising healthcare diagnostics, growing printing needs in commercial packaging, and advances in digital imaging. Additionally, increased investments in medical infrastructure and research have contributed to market expansion. Environmental concerns have led to the development of eco-friendly and biodegradable imaging chemicals. The market is also witnessing a shift toward digital and hybrid imaging, pushing manufacturers to innovate sustainable formulations.

Imaging Chemicals Market- Market Dynamics

Growing demand for contrast agents in advanced diagnostic imaging procedures.

One niche driver for the imaging chemicals market is the growing demand for contrast agents in advanced diagnostic imaging procedures. Contrast agents are essential chemicals used in imaging to enhance the visibility of internal body structures, making it easier for physicians to detect abnormalities. As medical imaging technologies like MRI, CT scans, and angiography become more sophisticated, the need for high-quality contrast chemicals has surged. These agents help differentiate between tissues, blood vessels, and organs, leading to more accurate diagnoses.

With the rising prevalence of chronic diseases such as cancer and cardiovascular conditions, the demand for precise and early detection tools has increased, further boosting the use of imaging chemicals. In addition, the aging population and increased access to healthcare services in emerging economies are expanding the patient pool undergoing diagnostic scans. Technological advancements in contrast media, such as low-toxicity and targeted agents, have also supported market growth. Moreover, ongoing research into personalized medicine and molecular imaging is driving the development of specialized contrast chemicals tailored for individual patients. This trend reflects the critical role imaging chemicals play in enhancing medical outcomes through high-resolution diagnostics.

Imaging Chemicals Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.5% over the forecast period (2025-2032)

Based on product type segmentation, MRI Contrast Agents were predicted to show maximum market share in the year 2024

Based on application segmentation, Medical Diagnostics was the leading application in 2024

Based on Formulation segmentation, Fixers was the leading Formulation in 2024

Based on region, North America was the leading revenue generator in 2024

Imaging Chemicals Market- Segmentation Analysis:

The Global Imaging Chemicals Market is segmented based on Product Type, Application, Formulation, End-user, and Region.

The market is divided into six categories based on product type: X-ray Imaging Chemicals, MRI Contrast Agents, Ultrasound Contrast Agents, Photographic Chemicals, Printing Imaging Chemicals, and Industrial Imaging Chemicals. Medical Diagnostics is the most superior component in the imaging chemicals market in terms of product type. They have found wide application in magnetic resonance imaging by making the internal organs, tissues, and vascular structures visible to make an accurate diagnosis of complex medical conditions. This is facilitated by the fact that neurological, cardiovascular, and cancer-related diseases are on the increase globally and are accompanied by the need to focus on high-precision imaging.

Also, the particular modality that is associated with non-invasiveness and non-ionizing radiation is MRI. Due to advancing interests in the healthcare systems that involve investing in improved diagnostic technologies, there is a growing demand for the use of MRI contrast chemicals. Development of safer and low-toxicity formulations of contrast agents, as well as advancement of targeted contrast agents, has further driven their applications. The older population and the increased knowledge in early disease diagnosis are also the organizers of this segment's leadership.

The market is divided into two categories based on application: Medical Diagnostics, Photography, Printing & Packaging, Textile Imaging, Semiconductor & Electronics, and Industrial Non-Destructive Testing (NDT). Medical Diagnostics is the most commanding segment in the imaging chemicals market based on application. This section is at the frontline because of the popularity of imaging methods of detection and monitoring of diseases such as MRI, CT scans, X-rays, and ultrasound. The detection and visualization of contrast agents (imaging chemicals) are needed to increase the clarity and accuracy of the diagnostic images. The demand to meet the increasing global burden of chronic diseases like cancer, cardiovascular disorders, and neurological disorders requires the need to have accurate imaging solutions.

The technological activity in imaging Devices, combined with the growth of health care infrastructure, particularly in developing economies, contributes to additional growth. The increased number of aging populations and early diagnosis programs is also a factor in increased volumes of imaging. The segment is enjoying the success of keeping on developing low-risk, patient-friendly chemical formulations. On the whole, medical diagnostics will again become the focus of the evolution of the market.

Imaging Chemicals Market- Geographical Insights

The North American imaging chemicals market is driven primarily by the strong presence of advanced healthcare infrastructure and rising demand for diagnostic imaging procedures. The United States dominates the regional market due to high investment in medical technologies and widespread use of contrast agents in CT, MRI, and X-ray applications. Growth is also fueled by increasing incidences of chronic diseases requiring accurate and early detection. The printing and packaging sectors contribute significantly, especially with the continued demand for high-resolution, durable prints.

In the United States, technological advancements in eco-friendly and digital-compatible imaging chemicals are being adopted rapidly. Regulatory frameworks by agencies like the FDA and EPA influence the development of safer, low-toxicity chemicals. Canada follows with growing investments in medical diagnostics and industrial imaging. Regional companies are also emphasizing sustainable formulations to meet environmental standards. Research collaborations between manufacturers and healthcare providers are further enhancing innovation in this space.

Imaging Chemicals Market- Competitive Landscape:

The competitive landscape of the imaging chemicals market is characterized by the presence of several global and regional players focusing on innovation and sustainability. Companies like Fujifilm, Agfa-Gevaert, and Eastman Kodak dominate with broad product portfolios and strong R&D capabilities. The market is moderately consolidated, with a few major players controlling a significant share in the medical and photographic imaging segments. Strategic collaborations, acquisitions, and geographic expansion are common to gain a competitive edge. Firms are investing in eco-friendly and biodegradable chemicals to align with environmental regulations and consumer demand.

Asia-Pacific, particularly Japan and China, hosts key manufacturers with advanced production technologies. In contrast, North American and European players emphasize healthcare imaging and digital printing. Competitive pricing and product differentiation are essential strategies in this space. Additionally, niche players are emerging with specialized formulations for diagnostic and industrial imaging. Innovation in contrast agents and digitally compatible chemicals is shaping the future landscape.

Recent Developments:

In June 2024, Bayer submitted a New Drug Application (NDA) in the U.S. for a novel MRI contrast agent. This marks a strategic move to expand its medical imaging portfolio and enhance diagnostic precision.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as following:

GLOBAL IMAGING CHEMICALS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

GLOBAL IMAGING CHEMICALS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

GLOBAL IMAGING CHEMICALS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

GLOBAL IMAGING CHEMICALS MARKET, BY FORMULATION- MARKET ANALYSIS, 2019 - 2032

GLOBAL IMAGING CHEMICALS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

GLOBAL IMAGING CHEMICALS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

Table of Contents

1. Imaging Chemicals Market Overview

2. Executive Summary

3. Imaging Chemicals Key Market Trends

4. Imaging Chemicals Industry Study

5. Imaging Chemicals Market: Impact of Escalating Geopolitical Tensions

6. Imaging Chemicals Market Landscape

7. Imaging Chemicals Market - By Product Type

8. Imaging Chemicals Market - By Application

9. Imaging Chemicals Market - By Formulation

10. Imaging Chemicals Market - By End-user

11. Imaging Chemicals Market- By Geography

12. Key Vendor Analysis- Imaging Chemicals Industry

13. 360 Degree AnalystView

14. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â